Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Mastectomy Reconstruction Outcomes Consortium (MROC) Study
The Mastectomy Reconstruction Outcomes Consortium (MROC) study, sponsored by the University of Michigan, has completed and reports outcomes …
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
A completed clinical trial evaluating diagnostic procedures for women with locally advanced breast cancer who are receiving chemotherapy bef…
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
The clinical trial evaluating breast cancer risk in BRCA1/BRCA2 mutation carriers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating ruxolitinib in combination with capecitabine in advanced or metastatic HER2-negative breast cancer was terminated.
-
CLINICAL_TRIALS research · 2017-07-12Clinical Trial Update: Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
This clinical trial update investigates cardiotoxicity risk from trastuzumab in breast cancer patients by using cardiac magnetic resonance i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-07-12Clinical Trial Update: L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer [Phase 1]
Phase 1 trial evaluating L-glutamine to alleviate taxane-induced neuropathy in breast cancer patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer [Phase 2]
Phase 2 trial evaluating vitamin D deficiency and musculoskeletal symptoms (muscle pain, joint pain, and joint stiffness) in postmenopausal …
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer [NA]
A completed clinical trial assessing whether dexamethasone plus either ondansetron or palonosetron reduces nausea and vomiting in patients w…
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: Digital Mammography Screening Trial (ACRIN6652) [NA]
The Digital Mammography Screening Trial (ACRIN6652), sponsored by the American College of Radiology Imaging Network, has completed its study…
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating neoadjuvant chemotherapy followed by radiotherapy alone in patients with breast cancer; the current s…
-
CLINICAL_TRIALS withdrawal · 2017-07-11Clinical Trial Update: Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer [Phase 2, Phase 3]
Peregrine's Phase 2/3 study evaluating taxane chemotherapy with or without bavituximab for HER2-negative metastatic breast cancer has been w…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer [Phase 2]
Phase II trial evaluating liposomal cytarabine with high-dose methotrexate for central nervous system metastases from breast cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer [Phase 4]
Phase IV trial evaluating the palliative benefit of pamidronate or zoledronic acid in breast cancer has completed.
-
CLINICAL_TRIALS research · 2017-07-07Clinical Trial Update: The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers [Phase 2]
A Phase 2 clinical trial called EMPOwER is evaluating multiparameter gene testing as a predictor of short-term endocrine therapy response in…
-
CLINICAL_TRIALS research · 2017-07-07Clinical Trial Update: Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer
This clinical trial update describes an ongoing study evaluating eating habits and taste disturbances (dysgeusia) in patients receiving chem…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Comparing Patient Satisfaction of the Abdomen After DIEAP Procedure and Conventional Abdominoplasty
A completed trial comparing patient satisfaction and donor-site outcomes between DIEAP flap breast reconstruction and conventional abdominop…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Female Cancer Patients' Preference For Sexual Health Interventions
A completed clinical trial update from Memorial Sloan Kettering Cancer Center exploring female cancer patients' preferences for sexual healt…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
This clinical trial update reports on a completed pilot study evaluating bone mineral density changes in postmenopausal women after breast c…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
A completed clinical trial from the University of Michigan Rogel Cancer Center evaluated the feasibility of quantifying apoptosis and Bcl-2 …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone [Phase 2]
Phase 2 trial evaluating dasatinib in patients with stage IV breast cancer that has spread to the bone has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy [Phase 2]
Completion of a Phase 2 trial evaluating melatonin as a circadian regulator, neuromodulator, and myelo-protector in adjuvant breast cancer c…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer [Phase 2]
Phase 2 trial evaluating CDX-011 (CR011-vcMMAE) for advanced GPNMB-expressing breast cancer has completed enrollment. The sponsor of the stu…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer [Phase 3]
Phase 3 trial update evaluating safety of subcutaneously administered trastuzumab (Herceptin) in early and locally advanced HER2-positive br…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen [Phase 2]
This Phase 2 clinical trial update describes a study of blood samples from women with breast cancer or ductal carcinoma in situ who are rece…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial of bevacizumab for inflammatory breast cancer and locally advanced breast cancer has completed.